Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus

Molecular Carcinogenesis

Volumn 15, Issue 2, 1996, Pages 154-161

  Walker, Cheryl ^a   Ahn, Yong Tae ^a   Everitt, Jeffrey ^b   Yuan, Xiaoqin ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

Eker rat; Kidney; Renal cell carcinoma; VHL

Indexed keywords

ANIMAL CELL; ARTICLE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ANIMALIA; MARTES PENNANTI;

EID: 0029873431     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199602)15:2<154::AID-MC8>3.0.CO;2-J     Document Type: Article

References (49)

1. Seizinger BR, Rouleau GA, Ozelius LI, et al. von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332:268-269, 1988.
2. Tory K, Brauch H, Linehan M, et al Specific genetic change in tumors associated with von Hippel-Lindau disease J Natl Cancer Inst 81:1097-1101, 1989
3. Kovacs G, Emanuel A, Neumann HPH, Kung H-F. Cytogenetics of renal cell carcinomas associated with von Hippel-Lindau disease Genes Chromosom Cancer 3 256-262, 1991.
4. Latif F, Tory K, Gnarra J, et al. Identification of the von HippelLindau disease tumor suppressor gene Science 260:1317-1320, 1993
5. Kanno H, Kondo K, Ito S, et al. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas Cancer Res 54:4845-4847, 1994
6. Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL. tumour suppressor gene in renal carcinoma Nat Genet 7:85-90, 1994.
7. Shuin T, Kondo K, Torigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippei-Lindau tumor suppressor gene in primary human renal cell carcinoma. Cancer Res 54:2852-2855, 1994
8. Whaley JM, Naglich J, Gelbert L, et al. Germline mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinomaAm J Hum Genet 55:1092-1102, 1994
9. Sekido Y, Bader S, Latif F, et al Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 9:1599-1604, 1994
10. Thoenes W, Storkel ST, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas) The basic cytological and histopathological elements and their use for diagnostics Pathol Res Pract 181:125-143, 1986.
11. Kovacs G. Molecular cytogenetics of renal cell tumors Adv Cancer Res 62:89-124, 1993
12. Tennant RW Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard. Mutat Res 286 111-118, 1993.
13. Eker R, Mossige J. A dominant gene for renal adenomas in the rat Nature 189:858-859, 1961
14. Everitt J, Goldsworthy T, Wolf D, Walker C Hereditary renal cell carcinoma in the Eker rat: A rodent familial cancer syndrome. J Urol 148 1932-1936, 1992
15. Yeung RS, Xiao G-H, Jin F, Lee W-C, Testa JR, Knudson AG Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene Proc Natl Acad Sci USA 91 11413-11416, 1994.
16. Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dommantly inherited cancer Nat Genet 9-70-74, 1995.
17. Walker C, Recio L, Funaki K, Everitt J. Cytogeneticand molecular correlates between rodent and human renal cell carcinoma In: Klein-Szanto A, Anderson M, Barrett JC, Slaga TJ (eds), Comparative Molecular Carcinogenesis. Wiley-Liss, New York, 1992, pp 289-302
18. Eker R, Mossige J, Johannessen JV, Aars H. Hereditary renal adenomas and adenocarcinomas in rats. Diagnostic Histopathology 4.99-110, 1981.
19. Wolf DC, Whiteley HE, Everitt JI. Preneoplastic and neoplastic lesions of rat hereditary renal cell tumors express markers of proximal and distal nephron Vet Pathol, in press.
20. Recio L, Lane SC, Ginsler J, Walker C. Analysis of ras DNA sequences in rat renal cell carcinoma. Mol Carcinog 4:350-353, 1991.
21. Horesovsky G, Recio L, Everitt J, Goldsworthy T, Wolf DC, Walker C. p53 status in spontaneous and dimethylnitrosamine-induced renal cell tumors from rats. Mol Carcinog 12.236-240, 1995.
22. Walker LC, Everitt J, Freed JJ, Knudson Jr AG, Whiteley LO. Altered expression of transforming growth factor-α in hereditary rat renal cell carcinoma. Cancer Res 51:2973-2978, 1991.
23. Gomella LG, Sargent ER, Wade TP, Anglard P, Linehan WM, Kasid A. Expression of transforming growth factor α in normal human adult kidney and enhanced expression of transforming growth factors α and β1 in renal cell carcinoma Cancer Res 49:6972-6976, 1989.
24. Mydlo JH, Michaeli J, Cordon-Cardo C, Goldenberg AS, Heston WDW, Fair WR. Expression of transforming growth factor α and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res 49:3407-3411, 1989.
25. Atlas I, Mendelsohn J, Baselga J, Fair WR, Masui H, Kumar R. Growth regulation of human renal carcinoma cells Role of transforming growth factor α. Cancer Res 52:3335-3339, 1992.
26. Nanus DN, Mentle IR, Motzer RJ, Bander MH, Albino AP Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol 143 175-178, 1990.
27. Nlagata Y, Abe M, Kobayashi K, et al Point mutations of c-ras genes in human bladder cancer and kidney cancer. Jpn J Cancer Res 81:22-27, 1990.
28. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 53:3092-3097, 1993
29. Suzuki Y, Tamua G, Satodate R, Fujioka T Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn J Cancer Res 83:233-235, 1992.
30. Uchida T, Wada C, Shitara T, Egawa S, Mashimo S, Koshiba K Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumongenesis of renal cell carcinoma. J Urol 150:1298-1301, 1993.
31. Uchida T, Wada C, Wang C, Egawa S, Ohtani H, Koshiba K. Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma Cancer Res 54:3682-3685, 1994.
32. Funaki K, Everitt J, Oshimura M, Freed JJ, Knudson AG, Walker C Hereditary renal cell carcinoma in the rat associated with non-random loss of chromosomes 5 and 6. Cancer Res 51:4415-4422, 1991.
33. Aldaz CM, Yeung RS, Latif F, et al. Colocalization of the rat homologue of the VHL gene and Atpb2 gene to rat chromosome bands 4q41 3-42.1. Cytogenet Cell Genet 71:253-256, 1995.
34. Walter TA, Berger CS, Sandberg AA The cytogenetics of renal tumors: Where do we stand, where do we go? Cancer Genet Cytogenet 43:15-34, 1989
35. Zbar B Chromosomal deletions in lung cancer and renal cancer. Important Adv Oncol 41-60, 1989
36. Hinton DE, Heatfield BM, Lipsky MM, Trump BF Renal tubular carcinoma, Model No. 211 In: Capen CC, Hackel DB, Jones TC, Migaki G (eds), A Handbook: Animal Models of Human Disease, Fasc 10 Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington DC, 1981, 4 pp
37. Bannasch P, Krech R, Zerban H. [Morphogenesis and micromorphology of epithelial tumors induced in the rat kidney by nitrosomorpholine II. Tubular glycogenosis and the genesis of clear or acidophilic cell tumors (authors' translation)]. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 92:63-86, 1978.
38. Freed JJ, Howard S, Lerro A, Dodson L, Knudson AG Hereditary renal tumors in the Eker rat: Cell lines from adenocaranomas induced by the Eker mutation. Proceedings of the American Association for Cancer Research 31:317, 1990
39. HinoO, Klein-Szanto AJP, Freed JJ, et al. Spontaneous and radiation-induced renal tumors in the Eker rat model of dommantly inherited cancer. Proc Natl Acad Sci USA 90.327-331, 1993.
40. Walker C, Ginsler J Development of a quantitative in vitro transformation assay for kidney epithelial cells. Carcinogenesis 1.25-32, 1992
41. Walker LC, Rutten F, Yuan X, Pass H, Mew DM, Everitt J. Wilms' tumor suppressor gene expression in rat and human mesothelioma. Cancer Res 54:3101-3106, 1994.
42. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294-5299, 1979.
43. Ausubel FM, Brent R, Kingston RE, et al (eds), Current Protocols in Molecular Biology. John Wiley & Sons inc., New York, 1989.
44. Gau J, Naglich JG, Laidlaw J, Whaley JM, Seizmger BR, Kley N. Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: Implications for the potential organization of the human von Hippel-Lindau disease gene. Cancer Res 55-743-747, 1995.
45. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumorsuppressor gene by DNA methylation in renal carcinoma Proc Natl Acad Sci USA 91:9700-9704, 1994.
46. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development- Mol Cell Biol 11:1707-1712, 1991.
47. Cohn C, McCue PA, Derose PB. Histogenesis of renal cell carcinoma and renal oncocytoma: An immunohistochemical study. Cancer 62.1946-1951, 1988
48. Droz D, Zachar D, Charbit L, Gogusev J, Chretien Y, Iris L. Expression of the human nephron differentiation molecules in renal cell carcinoma. Am J Pathol 137.895-905, 1990.
49. Ito N, Hiasa Y, Kamakoto Y, et al. Histopathological analysis of kidney tumors in rats induced by chemical carcinogens. Gann 62:435-444, 1971.